Latest Breaking News On - Sanjeev panchal - Page 1 : comparemela.com

CDSCO gives nod to AstraZeneca India s drug for Gastric and HER2-Low Metastatic Breast cancer - Pharma News

CDSCO gives nod to AstraZeneca India s drug for Gastric and HER2-Low Metastatic Breast cancer - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Sanjeev panchalCentral drugs standard control organisationAstrazeneca pharma india limited onWorld health organisationAstrazeneca pharma india limitedLow metastatic breast cancerMetastatic gastric cancerDrug controller generalCountry presidentManaging directorAstrazeneca indiaAnil kukrejaMedical affairs

AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications

AstraZeneca Pharma gets CDSCO nod for Trastuzumab deruxtecan use for 2 more indications
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Sanjeev panchalCentral drugs standard control organisationAstrazeneca pharma indiaDrugs controller general

AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine

AstraZeneca Pharma India Ltd and Mankind Pharma Ltd on Monday said they have entered into an agreement for exclusive distribution of the Symbicort brand, an asthma medicine, in India. Symbicort is owned by AstraZeneca, which will retain the intellectual property rights and will continue to be the

Sanjeev panchalAtish majumdarMankind pharma ltd onAstrazeneca pharma india ltdMankind pharma ltdAstrazeneca pharma indiaMankind pharmaZeneca india managing directorCountry president sanjeev panchalSenior presidentAnkind pharma ink pact to distribute asthma medicine

AstraZeneca: Mankind Pharma enters exclusive pact to distribute AstraZeneca s anti-asthma drug Symbicort in India

AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca will retain the intellectual property rights to Symbicort and continue as the marketing authorization holder. Symbicort, a top-selling product globally for AstraZeneca, recorded sales of around $2.4 billion in 2023.

United kingdomAtish majumdarSanjeev panchalAstrazeneca pharma indiaMankind pharma

AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine | Central India s Premier English Daily

AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine | Central India s Premier English Daily
centralchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from centralchronicle.com Daily Mail and Mail on Sunday newspapers.

Sanjeev panchalAtish majumdarMankind pharmaAstrazeneca pharma indiaAstrazeneca pharma india limited